Mint-risperidon Tablet: Out Of Specification (impurity)
Mint-Risperidon 0.25 mg tablets are being recalled across Canada because they contain an out-of-specification impurity. This is a Class I recall, which means the product could cause serious health problems. The recall affects all Mint-Risperidon 0.25 mg tablets distributed in Canada.
- Product
- Mint-Risperidon 0.25 mg tablet
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-09-27
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/2f8b43a5-519f-4ac5-bd0f-cbb302f06cb9